What is it about?
Monitoring clot formation in whole blood is difficult with routine lab tests. We mixed sucrose-coated magnetic nanoparticles into fresh human blood and applied an alternating field. A magnetic readout that depends on how freely the particles rotate dropped as clotting trapped them. Anticoagulant drugs slowed this drop, including direct oral anticoagulants that routine tests often miss.
Featured Image
Why is it important?
This measures clot formation and compaction in whole blood, not just plasma chemistry. It uses nanoscale probes, so it can pick up changes in blood mechanics as the clot develops in real time. The method detected the effect of several clinically used anticoagulants in a dose-dependent way. It could complement current coagulation testing when rapid, whole-blood monitoring is needed. It also creates a path to more selective probes that track specific clot components without altering clotting.
Perspectives
I found it compelling that one magnetic signal could follow clotting continuously in whole blood. A key choice was focusing on the rotation-sensitive part of the signal, which falls as particles immobilize in the clot. An important insight was that drug effects are clearest when you compare full time-courses, not a single endpoint. Next, I would optimize the nanoparticle coating so it acts only as a sensor and does not nudge the intrinsic pathway. More broadly, this approach could improve how we monitor anticoagulation and study clot structure outside the body.
Dr Daniel Ortega
Universidad de Cadiz
Read the Original
This page is a summary of: Magnetic coagulometry: towards a new nanotechnological tool for ex vivo monitoring coagulation in human whole blood, Nanoscale, January 2024, Royal Society of Chemistry,
DOI: 10.1039/d3nr02593d.
You can read the full text:
Contributors
The following have contributed to this page
